Vimab Group AB (publ) (STO:VIMAB)

Vimab Group AB Revenue

Vimab Group AB had revenue of 94.19M SEK in the quarter ending June 30, 2026, with 11.31% growth. This brings the company's revenue in the last twelve months to 351.85M, up 14.84% year-over-year. In the year 2025, Vimab Group AB had annual revenue of 328.64M, down -0.49%. That makes Vimab Group AB the 30,555th largest company in the world by revenue and 391st in Sweden.

• Revenue (ttm): 351.85M
• Revenue Growth: +14.84%
• P/S Ratio: 0.36
• Revenue / Employee: 1.99M
• Employees: 170
• Market Cap: 123.19M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	328.64M	-1.61M	-0.49%
Dec 31, 2024	330.25M	-17.57M	-5.05%
Dec 31, 2023	347.82M	118.57M	51.72%
Dec 31, 2022	229.25M	20.21M	9.67%
Dec 31, 2021	209.04M	19.47M	10.27%
Dec 31, 2020	189.57M	6.45M	3.52%
Dec 31, 2019	183.13M	-90.35M	-33.04%
Dec 31, 2018	273.48M	66.28M	31.99%
Dec 31, 2017	207.19M	63.61M	44.31%
Dec 31, 2016	143.58M	-10.38M	-6.74%
Dec 31, 2015	153.96M	15.62M	11.29%
Dec 31, 2014	138.34M	17.61M	14.58%
Dec 31, 2013	120.73M	-14.57M	-10.77%
Dec 31, 2012	135.30M	-	-

Data Source: Fiscal.ai Last updated: Aug 22, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 15, 2026

Data Sources Report a data error